 beneﬁt
for patients with VLUs that do not respond to an initial
treatment course of standard therapy. Split-thickness skin
grafting may provide beneﬁt, particularly for large, recalcitrant VLUs. Cellular therapy with Apligraf was found to be
beneﬁcial in a multicenter randomized clinical trial, as was
porcine small intestinal submucosa. There have been no
comparative trials of these therapies published with